Submitted:
19 July 2025
Posted:
21 July 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Material and Methods
3. Results
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Use of Artificial Intelligence
Conflicts of Interest
References
- Rhodes, J. Comparative physiology of hypoxic pulmonary hypertension: Historical clues from brisket disease. J. Appl. Physiol, 2005, 98(3), 1092-1100. [CrossRef]
- Moxley, R.A.; Smith, D.R., Grotelueschen, D.M.; Edwards, T; Steffen, D.J.; Investigation of congestive heart failure in beef cattle in a feedyard at a moderate altitude in western Nebraska. J. Vet. Diag. Invest. 2019, 31(4), 509–522. [CrossRef]
- Holt, T.N.; Callan, R.J. Pulmonary arterial pressure testing for high mountain disease in cattle. Vet. Clin. North Am. Food Anim. Pract. 2007, 23(3), 575–96. [Google Scholar] [CrossRef] [PubMed]
- Riet-Correa, F.; Michelooud, J.; Machado, M.; Mendonça, F.; Schild, A.L.; Lemos, R.L. Intoxicaciones por plantas, micotoxinas y otras toxinas en rumiantes y équidos en Sudamérica Gurnee: Davis-Thompson Foundation; 2024. 507 p.
- Boghossian, M.R.; Peixoto, P.V.; Brito, M.F.; Tokarnia, C.H. Aspectos clínico-patológicos da intoxicação experimental pelas sementes de Crotalaria mucronata (Fabaceae) em bovinos. Pesq. Vet. Bras. 2007, 27(4), 149–156. [Google Scholar] [CrossRef]
- Dourado, C.S., Oliveira, S.R.M.; de Avila, A.M.H. Análise de zonas homogêneas em séries temporais de precipitação no Estado da Bahia. Bragantia, Campinas, 2013, 72 (2),192-198.
- Souza, A.Z.S.N. Edema crônico em bovinos no Estado da Bahia. Ms thesis. Federal University of Bahia. Bahia, Brazil, 2021; pp.93.
- James, L.F; Panter, K.E.; Broquist, H.P; Hartley, WJ. Swainsonine-induced high mountain disease in calves. Vet. Human Toxicol 1991, 33, 217–219. [Google Scholar]
- Oliveira,, C.A.; Riet-Correa, G.; Lima, E.; Medeiros, R.M.T,; Miraballes, C.; Pfister J.A,; Gardner, D.; Cook D.; Riet-Correa, F. Toxicity of the swainsonine-containing plant Ipomoea carnea subsp. fistulosa for goats and sheep. Toxicon 2021, 197, 40–47. [CrossRef]
- Caymmi, L.G. Perfil clínico-epidemiológico e anatomopatológico de uma doença caraterizada por edema crônico em bovinos no estado da Bahia. PhD thesis. Federal University of Bahia. Bahia, Brazil, 2025; pp.61.
- Hulsmans, M.; Nahrendorf, M. Proliferative, degradative smooth muscle cells promote aortic disease. J, Clin. Invest. 2021, 130(3), 1096-1098. [CrossRef]
- Lee, Y.S.; Byun, B.J.; Kim, J.A.; Lee, J.S.; Kim, K.L.; Suh, Y.L.; Kim, J.M.; Jang, H.S.; Lee, J.Y.; Suh, W.; Jeon, E.S.; Kim, D.K. Monocrotaline-induced pulmonary hypertension correlates with upregulation of connective tissue growth factor expression in the lung. Exp. Molec. Med. 2005, 37, 27–35. [Google Scholar] [CrossRef] [PubMed]
- Gordon, R.J.; Hungerford, N.L.; Laycock, B.; Fletcher, M.T. A review on Pimelea poisoning of livestock. Toxicon 2020, 186, 46–57. [Google Scholar] [CrossRef] [PubMed]



| Outbreak | Month/Year | Municipality | N° of cattle | N° affected cattle | N° dead cattle | Age of affected cattle | Sex affected cattle |
|---|---|---|---|---|---|---|---|
| 1 | Oct/2023 | Mairi | 415 | 11 (2,6%) | 5 (45%) | 3 years | M |
| 2 | Nov/2023 | Maracás | 160 | 22 (13,7%) | 9 (41%) | 4 years | F |
| 3 | Nov/2023 | Irajuba | 390 | 10 (2,5%) | 7 (70%) | 3-4 years | M and F |
| 4 | Dec/2023 | Mirangaba | 60 | 10 (16,7%) | 4 (40%) | 3 years | F |
| 5 | Dec/2023 | Jaguaquara | 450 | 20 (4,4%) | 6 (30%) | 3 years | F |
| 6 | Dec/2023 | Lajedinho | 2.000 | 50 (2,5%) | 15 (30%) | 3-4 y 4-6 m |
F |
| 7 | May/2024 | Ruy Barbosa | 300 | 10 (3,3%) | 4 (40%) | 2-3 years | M |
| 8 | Apr/2025 | Seabra | 11 | 4 (36,4%) | 1 (25%) | 2 – 3 anos | M and F |
| 9 | Dec/2023 | Jacobina | 200 | 3 (1,5%) | 3 (100%) | 2-4 years | M |
| 10 | Dec/2023 | Mundo novo | 93 | 7 (7,5%) | 4 (57%) | 2-3 years | M and F |
| 11 | Dec/2023 | Umburanas | 32 | 4 (12%) | 3 (75%) | 2 anos | M |
| 12 | Dec/2023 | Lajedinho | 67 | 3 (4%) | 1 (33%) | 2-3 years | F |
| 13 | Dec/2023 | Itaberaba | 123 | 10 (8,1%) | 7 (70%) | 2-3 anos | M and F |
| 14 | Dez/2023 | Jaguaquara | 45 | 4 (9%) | 2 (50%) | 2-3 anos | F |
| 15 | Dec/2023 | Jequié | 80 | 8 (10%) | 5 (62%) | 2-3 anos | M |
| OUTBREAKS | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | Reference values* |
|---|---|---|---|---|---|---|---|---|---|
| PCV (%) | 23±3,4 | 25±5,1 | 32±3 | 29±5,7 | 34±5,5 | 21±3,9 | 22±3,2 | 24±1,7 | 24 – 46 |
| RBC(106/μL) | 4,9±1 | 5,5±1,5 | 6,8±1,5 | 6,6±1,4 | 6,5±1,1 | 4,2±0,9 | 5,0±0,9 | 3,5±0,3 | 5 – 10 |
| Hb (g/dL) | 8±1,1 | 8±1,7 | 11±1 | 9,5±1,9 | 11±1,8 | 7±1,3 | 7,5±1,0 | 7,9±0,5 | 8 – 15 |
| MPCV (fL) | 49±8,8 | 47±5,9 | 49±8 | 44±3 | 50±2,8 | 52±9,2 | 45±4,7 | 67±2,8 | 40 – 60 |
| MPVH (%) | 33 ± 0 | 33,1±0,1 | 33 ± 0 | 33 ± 0 | 33 ± 0 | 33 ± 0 | 33 ± 0 | 33,1 ±0 | 30 – 36 |
| Leukocites (μl) | 6,080 ±360 |
7,950 ±3.480 |
9,700 ±2,700 |
5,250 ±1,740 |
8.240 ±3,450 |
6,235 ±2,581 |
6,730 ±1,628 |
4,970 ±1,400 |
4000 – 12000 |
| Rods (μl) | 109±326 | 10±32 | 26±45 | 49±88 | 0±0 | 104±115 | 40±64 | 305±68 | 0 – 120 |
| Neutrphyles (μl) | 1,410 ±595 |
2,640 ±1,710 |
3,970 ±3,900 |
1,410 ±1,080 |
2,300 ±429 |
1,270 ±1,040 |
2,950 ±1,190 |
2,160 ±241 |
600 – 4000 |
| Eosinophils (μl) | 310±240 | 360±300 | 110±130 | 70±90 | 460±470 | 385±360 | 220±235 | 37±33 | 600 – 2400 |
| Basophils (μl) | 43 ± 60 | 0 ± 0 | 0±0 | 0 ± 0 | 0 ± 0 | 0 ± 0 | 0 ± 0 | 0 ± 0 | 0 – 200 |
| Linphocytes (μl) | 3,460 ±510 |
4,630 ±2,250 |
5,140 ±2,900 |
2,670 ±1,040 |
4,340 ±1,390 |
4,170 ±1,720 |
2,670 ±670 |
2,260 ±151 |
2500 – 7500 |
| Moncytes (μl) | 455±290 | 330±225 | 330±260 | 840 ±1,060 |
210±110 | 500±400 | 860±420 | 207±151 | 25 – 840 |
| Outbreak | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | Reference values* |
|---|---|---|---|---|---|---|---|---|---|
| TP (G/DL) | 6,4±0,5 | 6,6±0,6 | 8±0,3 | 6,9±1,3 | 7±0,4 | 6,6±0,7 | 6,7±0,3 | 5,6±0,6 | 6,7 – 7,4 |
| Albumin (g/dL) | 2,5±0,2 | 2,4±0,2 | 2,9±0,2 | 2,4±0,4 | 2,8±0,4 | 2,4±0,4 | 2,4±0,1 | 3,3±0,5 | 3 – 3,6 |
| Globulin (g/dL) | 3,9±0,3 | 4,1±0,5 | 5,0±0,2 | 4,5±1,6 | 4,2±0,4 | 4,1±0,5 | 4,3±0,3 | 2,5±0,2 | 3 – 3,5 |
| Urea (mg/dL) | 31±12 | 34±10 | 29±6 | 25±3 | 21±3 | 40±12 | 30±9 | 20±6,4 | 23 - 58 |
| Creatinine (mg/dL) | 2,3±0,6 | 1,6±0,3 | 1,8±0,4 | 1,4±0,2 | 1,8±0,3 | 2,1±0,3 | 1,5±0,3 | 1,2±0,1 | 1 – 2 |
| AST (UI) | 120±38 | 98,5±13 | 78±7,9 | 77±29,5 | 97,4±45,9 | 113±47,5 | 52±9,8 | 186±31,6 | 78 - 132 |
| GGT (μL) | 17±1,9 | 17,8±2,7 | 30±8,1 | 17±2,3 | 22±7 | 19±5,2 | 30±9,5 | 17,5±0,5 | 6,1 – 17,4 |
| CK (μL) | 272±180 | 211±242 | 79±18 | 133±20 | 238±250 | 190±170 | 337±330 | 1,434 ±1,109 |
35-280 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).